Investing.com - EDAP reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
EDAP announced earnings per share of €0.000 on revenue of €12.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of €-0.060 on revenue of €12.04M.
EDAP shares are up 65.94% from the beginning of the year and are trading at €9.940 , down-from-52-week-high.
EDAP follows other major Healthcare sector earnings this month
EDAP's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of €1.98 on revenue of €6.94B, compared to forecasts EPS of €1.91 on revenue of €6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of €1.78 on revenue of €22.6B, compared to forecast for EPS of €1.44 on revenue of €21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar